A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)

26 November 2021 : Case report USA

Unusual or unexpected effect of treatment

Anupamjeet Kaur Sekhon^1BDEF*, Aniruddha Gollapalli^1E, Dharamjeet Kaur^2E, Bryan Janssen^3D, Mark L. Stevens

^2E, Fernando Valerio^4AE, Miguel A. Sierra-Hoffman^2E

DOI: 10.12659/AJCR.932961

Am J Case Rep 2021; 22:e932961

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 2. Liver function tests from initial diagnosis.

Date	ALP (30–101 U/L)	AST (9–40 U/L)	ALT (5–40 U/L)
05/06/2013	99	85	114
12/04/2017	54	22	39
03/05/2018	49	22	37
06/06/2018	42	21	28
12/12/2018	36	24	31
03/12/2019	42	24	27
04/16/2019	48	847	138
05/15/2019	80	117	146
09/13/2019	119	66	135
11/20/2019	99	110	254
12/04/2019	76	741	1862
12/10/2019	140	366	1251
01/07/2020	118	53	133
02/24/2020	83	42	42
03/26/2020	93	33	33
09/04/2020	107	42	70
10/09/2020	103	25	32

Back to the Article